2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic …

AR Lyon, T Lopez-Fernandez, LS Couch… - European Heart …, 2022 - academic.oup.com
ESC Guidelines e341 (1) the specific situation of the patient. In this respect, it is specified
that, unless otherwise provided for by national regulations, offlabel use of medication should …

New approaches to management of pericardial effusions

G Lazaros, C Vlachopoulos, E Lazarou… - Current Cardiology …, 2021 - Springer
Abstract Purpose of Review Pericardial effusion is a challenging pericardial syndrome and a
cause of serious concern for physicians and patients due to its potential progression to life …

Chronic pericardial effusion: causes and management

G Lazaros, M Imazio, P Tsioufis, E Lazarou… - Canadian Journal of …, 2023 - Elsevier
Chronic pericardial effusion is a common pericardial syndrome whose approach has been
well standardised in recent years. The main challenge associated with this condition is the …

Pericardial effusion and cardiac tamponade pathophysiology and new approaches to treatment

BD Hoit - Current Cardiology Reports, 2023 - Springer
Abstract Purpose of Review The objective of this manuscript is to examine up-to-date
approaches to the diagnosis and treatment of pericardial effusions and cardiac tamponade …

Immune checkpoint inhibitor-associated cardiovascular toxicities: A review

G Liu, T Chen, X Zhang, B Hu, H Shi - Heliyon, 2024 - cell.com
Immune checkpoint inhibitors (ICIs) have revolutionary effects on therapeutic strategies for
multiple malignancies. Their efficacy depends on their ability to reactivate the host immune …

[HTML][HTML] Development of machine learning-based malignant pericardial effusion-related model in breast cancer: Implications for clinical significance, tumor immune …

W Zhan, H Hu, B Hao, H Zhu, T Yan, J Zhang, S Wang… - Heliyon, 2024 - cell.com
Background Malignant pericardial effusion (MPE) is a common complication of advanced
breast cancer (BRCA) and plays an important role in BRCA. This study is aims to construct a …

The year in cardiovascular medicine 2021: cardio-oncology

J Herrmann, T López-Fernández… - European heart …, 2022 - academic.oup.com
Publications in cardio-oncology have increased exponentially over the past two decades.
The Year in Cardiovascular Medicine: Cardio-Oncology 2020–21 covers the most recent …

The Year in Cardio-oncology 2022

T Ahmed, K Marmagkiolis, M Ploch… - Current Problems in …, 2023 - Elsevier
Cardiovascular disease and cancer are the leading causes of death worldwide. With advent
of novel and improved cancer therapies, a growing population of cancer patients with …

Construction and validation of a nomogram of risk factors for new-onset atrial fibrillation in advanced lung cancer patients after non-surgical therapy

J Chen, S Cao, Y Jin, W Rong, H Wang, S Xi… - Frontiers in …, 2023 - frontiersin.org
Objective Risk factors of new-onset atrial fibrillation (NOAF) in advanced lung cancer
patients are not well defined. We aim to construct and validate a nomogram model between …

Predictors of recurrence and survival in cancer patients with pericardial effusion requiring pericardiocentesis

T Ahmed, E Mouhayar, J Song… - Frontiers in …, 2022 - frontiersin.org
Aim This study investigated the factors predicting survival and the recurrence of pericardial
effusion (PE) requiring pericardiocentesis (PCC) in patients with cancer. Materials and …